From: Sonographic findings of thoracic empyema: outcome perspectives
Group I (17) | Group II (14) | Group III (19) | Group IV (22) | Total (72) | P value | |
---|---|---|---|---|---|---|
Age | ||||||
Mean ± SD | 41.3 ± 15.9 | 47.9 ± 11.7 | 42.6 ± 13.3 | 41.8 ± 12.2 | 43.1 ± 13.3 | 0.5 |
Sex, No. (%) | ||||||
Male | 10 (58.8%) | 9 (64.3%) | 11 (57.9%) | 12 (54.5%) | 42 (58.3%) | 0.95 |
Female | 7 (41.2%) | 5 (35.7%) | 8 (42.1%) | 10 (45.5%) | 30 (41.7%) | |
Comorbidities | ||||||
No | 8 (47.1%) | 3 (21.4%) | 11 (57.9%) | 12 (54.5%) | 34 (47.2%) | 0.17 |
DM | 4 (23.5%) | 5 (35.7%) | 3 (15.8%) | 5 (22.7%) | 17 (23.6%) | 0.62 |
HPN | 4 (23.5%) | 5 (35.7%) | 4 (21.1%) | 5 (22.7%) | 18 (25.0%) | 0.78 |
IHD | 1 (5.9%) | 2 (14.3%) | 0 (0.0%) | 1 (4.5%) | 4 (5.6%) | 0.36 |
COPD | 2 (11.8%) | 2 (14.3%) | 0 (0.0%) | 1 (4.5%) | 4 (5.6%) | 0.34 |
Malignancy | 1 (5.9%) | 0 (0.0%) | 0 (0.0%) | 1 (4.5%) | 2 (2.8%) | 0.61 |
Liver disease | 0 (0.0%) | 1 (7.1%) | 3 (15.8%) | 1 (4.5%) | 4 (2.8%) | 0.29 |
Renal disease | 0 (0.0%) | 1 (7.1%) | 1 (5.3%) | 2 (4.5%) | 4 (2.8%) | 0.66 |